CRNX
NASDAQStockCrinetics Pharmaceuticals, Inc.
$36.90-0.20 (-0.54%)
52-Week Range
$25.56
$56.43
Key Stats
Market Cap
3.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.24
Volume
671.3K
Avg Volume
1.1M
Performance
1M
-23.31%
3M
-27.69%
6M
+8.11%
YTD
-21.87%
1Y
+3.14%
3Y
+104.54%
5Y
+115.91%
Price Chart
ETF Exposure
CRNX is held by 90 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.05% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.04% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.03% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.03% |
| WSML | iShares MSCI World Small-Cap ETF | 0.03% |
| SMMD | iShares Russell 2500 ETF | 0.03% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.02% |
| HDG | ProShares - Hedge Replication ETF | 0.02% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| DFUS | Dimensional - US Equity Market ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.01% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
PreviousPage 2 of 2
About CRNX ETF Exposure
Crinetics Pharmaceuticals, Inc. (CRNX) is held by 90 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.9B, CRNX is a widely held institutional stock. The stock currently trades at $36.90. Investors can gain exposure to CRNX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CRNX, sorted by portfolio weight.